MET Receptors

More Information »The MET receptor, also known as hepatocyte growth factor receptor (HGFR), is a proto-oncogenic receptor tyrosine kinase. The endogenous ligand for MET is hepatocyte growth factor/scatter factor (HGF), a disulfide-linked heterodimeric molecule.

MET Receptor Products

Inhibitors
Cat.No.
Product Name / Activity
4368 Crizotinib
Potent c-MET/ALK inhibitor
1683 K 252a
Receptor tyrosine kinase inhibitor, inhibits MET
5369 Norleual
Highly potent HGF/c-MET inhibitor; also AT4 antagonist
4239 PF 04217903 mesylate
Highly selective MET inhibitor
2693 PHA 665752
Potent and selective MET inhibitor
5356 SGX 523
Selective and potent c-MET kinase inhibitor
4101 SU 11274
Selective inhibitor of MET kinase activity
3037 SU 5416
MET inhibitor. Also inhibits KIT, RET, VEGFR and FLT3
5422 XL 184
Potent c-MET inhibitor; also inhibits other RTKs
Related Categories

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Product Guide

Our Cancer Research Guide highlights over 750 products for cancer research. Request copy or view PDF today.

divider line

Kinase Inhibitor Toolbox

80 Kinase inhibitors
pre-dissolved in DMSO

Kinase Inhibitor Toolbox

Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.

divider line

Kinases Product Listing

Kinases Product Listing

Our Kinase listing highlights over 400 products for kinase research. Request copy or view PDF today.

divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Life Science Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance. Request copy today.

divider line

LinkedIn Updates

Follow Tocris on LinkedIn

Follow us on LinkedIn!

Visit our LinkedIn page for the latest Tocris news, events and updates.